Pharmacological prevention of renal ischemia-reperfusion injury in a rat model
Introduction: Renal ischemia–reperfusion injury (IRI) can lead to significant morbidity and mortality. It remains a leading cause of acute kidney injury and is therefore an important issue in trauma and renal transplant surgery. Various pharmaceutical agents have been used in an attempt to dampen the harmful effects of IRI but few have been shown to be useful clinically. Riluzole, Lidocaine and Lamotrigine have been demonstrated to show anti-ischaemic properties in other organs; however, their...[Show more]
|Collections||ANU Research Publications|
|Source:||ANZ Journal of Surgery|
|ANZ Journal of Surgery - 2021 - Deng.pdf||1.79 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.